Search

Your search keyword '"Horwitz JA"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Horwitz JA" Remove constraint Author: "Horwitz JA"
30 results on '"Horwitz JA"'

Search Results

1. HIV-1 Vpu restricts Fc-mediated effector functions in vivo.

2. Visualizing molecular interactions that determine assembly of a bullet-shaped vesicular stomatitis virus particle.

3. Structure of a rabies virus polymerase complex from electron cryo-microscopy.

4. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

5. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller.

6. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

7. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.

9. HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.

10. Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.

11. A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.

12. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.

13. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

14. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.

15. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.

16. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.

17. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.

18. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.

19. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice.

20. Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies.

21. Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein.

22. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

23. A genetically humanized mouse model for hepatitis C virus infection.

24. Biological performance of biodegradable amino acid-based poly(ester amide)s: Endothelial cell adhesion and inflammation in vitro.

25. Chorioretinal lesions in nonfatal cases of West Nile virus infection.

26. First report of prenatal biochemical diagnosis of Lowe syndrome.

27. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.

29. Episcleral nodule in systemic vasculitis.

Catalog

Books, media, physical & digital resources